Increased Insurance Coverage for Transcranial Magnetic Stimulation will Accelerate Demand
Transcranial Magnetic Stimulation has been consistently growing since 2008 when it was first FDA approved for treatment of depression in the United States. Insurance companies are easing the requirements coverage which will increase the demand.
Jan 1st, 2024